Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immunodeficiency (PID)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00168025
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 89
Large-scale testing (Phase 3)Not Yet RecruitingNCT07017036
What this trial is testing

Efficacy, Safety and Pharmacokinetic of Virchow IVIG in PID Patients

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Virchow Group 44
Not applicableStudy completedNCT03339778
What this trial is testing

The Benefit of 5% IVIG for Patients With Primary Immunodeficiency Disorders Who Experience Adverse Events on 10% IVIG Preparations

Who this might be right for
Primary Immunodeficiency
IMMUNOe Research Centers 15
Not applicableLooking for participantsNCT06565078
What this trial is testing

A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary Immunodeficiency

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 100
Early research (Phase 1)Looking for participantsNCT04691622
What this trial is testing

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

Who this might be right for
Viral InfectionHematopoietic Stem Cell Transplantation (HSCT)Primary Immunodeficiency Disorders (PID)
Children's National Research Institute 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07660783
What this trial is testing

Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

Who this might be right for
Bone Marrow FailureHemoglobinopathiesPrimary Immune Deficiency (PID)+4 more
Fred Hutchinson Cancer Center 40
Not applicableStudy completedNCT04636502
What this trial is testing

Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiencies (PID)
Shire 96
Large-scale testing (Phase 3)Study completedNCT00391131
What this trial is testing

Subcutaneous Ig NextGen 16% in PID Patients

Who this might be right for
Primary Immunodeficiency (PID)
CSL Limited 35
Large-scale testing (Phase 3)Active Not RecruitingNCT04944979
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 30
Not applicableUnknownNCT05476653
What this trial is testing

A Prospective Monocentric Study to Assess the Concordance of Lung MRI Compared to Chest CT Scan to Assess the Extent and Severity of Bronchial and Parenchymal Pulmonary Lesions in Adult Patients With Primary Immune Deficiency (PID) .

Who this might be right for
Primary Immune Deficiency
Hopital Foch 50
Not applicableStudy completedNCT05621876
What this trial is testing

Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia

Who this might be right for
Primary Immunodeficiency Diseases
PATH 50
Post-approval studies (Phase 4)Study completedNCT01289847
What this trial is testing

Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency

Who this might be right for
Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinemia+2 more
Bio Products Laboratory 25
Not applicableLooking for participantsNCT07261891
What this trial is testing

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)
prof. dr. Rik Schrijvers 20
Large-scale testing (Phase 3)Looking for participantsNCT07346859
What this trial is testing

Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency Diseases
Biopharma Plasma LLC 56
Large-scale testing (Phase 3)Study completedNCT00680446
What this trial is testing

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

Who this might be right for
Primary Immune Deficiency
CSL Limited 41
Post-approval studies (Phase 4)Not Yet RecruitingNCT07794735
What this trial is testing

TAK-664 in People With Primary Immunodeficiency Diseases Who Have Not Yet Been Treated With Immunoglobulins

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 9
Large-scale testing (Phase 3)Study completedNCT01814800
What this trial is testing

Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)

Who this might be right for
Primary Immune Deficiency Disorder
ADMA Biologics, Inc. 59
Testing effectiveness (Phase 2)Study completedNCT00161993
What this trial is testing

Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)

Who this might be right for
Primary Immunodeficiency Diseases (PID)AgammaglobulinemiaHypogammaglobulinemia
Baxalta now part of Shire 24
Post-approval studies (Phase 4)Study completedNCT07076446
What this trial is testing

An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency
CSL Behring 8
Large-scale testing (Phase 3)Study completedNCT05150340
What this trial is testing

TAK-771 in Japanese People With Primary Immunodeficiency Diseases (PID)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 16
Next Page